Gene Therapy For Hiv And Chronic Infections-..

Código: 1036415 Marca:
R$ 912,92 R$ 730,34
até 4x de R$ 182,58 sem juros
ou R$ 693,82 via Pix
Adicionar ao carrinho Disponibilidade: 45 dias úteis Estoque: 240 unidades
    • 1x de R$ 730,34 sem juros
    • 2x de R$ 365,17 sem juros
    • 3x de R$ 243,44 sem juros
    • 4x de R$ 182,58 sem juros
  • R$ 693,82 Pix
  • R$ 730,34 Boleto Bancário
* Este prazo de entrega está considerando a disponibilidade do produto + prazo de entrega.
This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.
ISBN 9781493924318
Autor(a) Berkhout, Ben
Editora Springer Publishing
Ano de edição 2015
Páginas 236
Acabamento Capa Dura
Dimensões 23,40 X 15,60

Produtos relacionados

R$ 912,92 R$ 730,34
até 4x de R$ 182,58 sem juros
ou R$ 693,82 via Pix
Adicionar ao carrinho Disponibilidade: 45 dias úteis Estoque: 240 unidades
Pague com
  • proxy-pagali-v2
  • Pix
Selos
  • Site Seguro

MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026


Para continuar, informe seu e-mail

Utilizamos cookies para que você tenha a melhor experiência em nosso site. Para saber mais acesse nossa página de Política de Privacidade